Volume | 1,109,808 |
|
|||||
News | (1) | ||||||
Day High | 15.058 | Low High |
|||||
Day Low | 13.70 |
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
NeoGenomics Inc | NEO | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
14.92 | 13.70 | 15.058 | 15.22 |
Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
---|---|---|---|---|---|
13,113 | 1,109,808 | US$ 14.09 | US$ 15,632,340 | - | 11.03 - 21.22 |
Last Trade | Type | Quantity | Price | Currency |
---|---|---|---|---|
13:58:30 | average | 100 | US$ 14.0802 | USD |
NeoGenomics (NEO) Options Flow Summary
NeoGenomics Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.8B | 127.61M | - | 591.64M | -87.97M | -0.69 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
NeoGenomics News
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NEO Price Data
Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 13.47 | 16.05 | 13.40 | 14.57 | 1,077,634 | 0.605 | 4.49% |
1 Month | 15.06 | 16.05 | 13.34 | 14.37 | 766,228 | -0.985 | -6.54% |
3 Months | 14.13 | 17.49 | 13.34 | 15.14 | 926,025 | -0.055 | -0.39% |
6 Months | 13.84 | 21.22 | 13.33 | 16.32 | 985,042 | 0.235 | 1.70% |
1 Year | 14.64 | 21.22 | 11.03 | 15.86 | 940,748 | -0.565 | -3.86% |
3 Years | 48.84 | 54.74 | 6.00 | 18.09 | 1,181,628 | -34.77 | -71.18% |
5 Years | 21.71 | 61.57 | 6.00 | 23.10 | 1,051,380 | -7.64 | -35.17% |
NeoGenomics Description
NeoGenomics Inc operates a network of cancer-focused genetic testing laboratories in the United States as well as a laboratory in Switzerland. The company operates into two segments namely Clinical Services and Pharma Services. It offers types of genetic and molecular testing services namely Cytogenetics, Fluorescence In-Situ Hybridization, Flow cytometry, Immunohistochemistry, Molecular testing, Pathology consultation. The company generates revenue from Clinical Services. |